Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 6;69(8):e2023D698.
doi: 10.1590/1806-9282.2023D698. eCollection 2023.

Use of intra-articular hyaluronic acid in knee osteoarthritis or osteoarthritis

Mauricio Anhesini  1 , Adriano Anzai  1 , Haroldo Katayama  1 , Ighor Alexander Zamuner Spir  1 , Mary Martins Nery  1 , Oswaldo Silvestrini Tiezzi  1 , Pericles Otani  1 , Wanderley Marques Bernardo  1
Affiliations
Editorial

Use of intra-articular hyaluronic acid in knee osteoarthritis or osteoarthritis

Mauricio Anhesini et al. Rev Assoc Med Bras (1992). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1.
Figure 1.. Flowchart of selected works.
Figure 2.
Figure 2.. Western Ontario McMaster University Osteoarthritis (WOMAC global) - IA-HA versus IA-SS.
Figure 3.
Figure 3.. Decreased pain at rest (VAS) - IA-AH versus IA-SS.
Figure 4.
Figure 4.. Lequesne’s functional index from 26 to 52 weeks - IA-HA versus IA-SS.
Figure 5.
Figure 5.. WOMAC (functional subscale) - score decrease - IA-HA versus IA-SS.
Figure 6.
Figure 6.. WOMAC (pain subscale) - score decrease - IA-HA versus IA-SS.
Figure 7.
Figure 7.. Decreased walking pain (VAS) - IA-HA versus IA-SS.
Figure 8.
Figure 8.. Adverse events - IA-AH versus IA-SS.
Figure 9.
Figure 9.. WOMAC pain score (12 and 26 weeks) - IA-HA versus IA-SS.
Figure 10.
Figure 10.. Pain assessment - VAS (12 and 26 weeks) - IA-HA versus IA-SS.
Figure 11.
Figure 11.. Pain assessment - overall WOMAC (26 and 52 weeks) - IA-HA versus IA-SS.
Figure 12.
Figure 12.. Adverse events - IA-HA versus IA-SS.
See this image and copyright information in PMC

References

    1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568–578. doi: 10.1001/jama.2020.22171. - DOI - PMC - PubMed
    1. Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17(2):152–160. doi: 10.1016/j.joca.2008.06.014. - DOI - PubMed
    1. Chevalier X, Jerosch J, Goupille P, Dijk N, Luyten FP, Scott DL, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69(1):113–119. doi: 10.1136/ard.2008.094623. - DOI - PMC - PubMed
    1. Day R, Brooks P, Conaghan PG, Petersen M, Multicenter Trial Crane A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31(4):775–782. - PubMed
    1. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993;1(2):97–103. doi: 10.1016/s1063-4584(05)80024-x. - DOI - PubMed

Publication types

Substances

LinkOut - more resources